NCT01711853View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

Dabigatran Etexilate

Dabigatran Etexilate 75mg twice daily

Trial Locations (1)

Unknown

1160.166.31001 Boehringer Ingelheim Investigational Site, Leiden

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY